|
G |
Adm |
adrenomedullin |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of ADM mRNA |
CTD |
PMID:33367866 |
|
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Adm2 |
adrenomedullin 2 |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of ADM2 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr 7:120,393,179...120,394,965
Ensembl chr 7:120,393,179...120,396,331
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
tris(chloroethyl)phosphate results in decreased expression of and results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:26378621 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Aplnr |
apelin receptor |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of APLNR mRNA |
CTD |
PMID:33367866 |
|
NCBI chr 3:70,217,407...70,221,052
Ensembl chr 3:70,217,385...70,221,050
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
tris(chloroethyl)phosphate binds to and results in decreased activity of AR protein |
CTD |
PMID:23398518 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of ASNS mRNA |
CTD |
PMID:33367866 |
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Atf4 |
activating transcription factor 4 |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of ATF4 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
C3ar1 |
complement C3a receptor 1 |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of C3AR1 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr 4:156,074,747...156,084,680
Ensembl chr 4:156,075,389...156,084,701
|
|
G |
C5ar1 |
complement C5a receptor 1 |
increases expression |
ISO |
tris(chloroethyl)phosphate results in increased expression of C5AR1 mRNA |
CTD |
PMID:29143341 |
|
NCBI chr 1:76,948,622...76,959,826
|
|
G |
C7 |
complement C7 |
decreases expression |
ISO |
tris(chloroethyl)phosphate results in decreased expression of C7 mRNA |
CTD |
PMID:29143341 |
|
NCBI chr 2:54,088,116...54,165,102
Ensembl chr 2:54,088,116...54,158,535
|
|
G |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
increases expression |
EXP |
tris(chloroethyl)phosphate results in increased expression of CAMK2A mRNA |
CTD |
PMID:24717766 |
|
NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994
|
|
G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
increases expression |
EXP |
tris(chloroethyl)phosphate results in increased expression of CAMK2B mRNA; tris(chloroethyl)phosphate results in increased expression of CAMK2B protein |
CTD |
PMID:24717766 |
|
NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994
|
|
G |
Cat |
catalase |
increases expression increases activity |
ISO EXP |
tris(chloroethyl)phosphate results in increased expression of CAT mRNA tris(chloroethyl)phosphate results in increased activity of CAT protein tris(chloroethyl)phosphate results in increased expression of CAT mRNA; tris(chloroethyl)phosphate results in increased expression of CAT protein |
CTD |
PMID:26049154 PMID:26183808 PMID:30974155 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cd36 |
CD36 molecule |
multiple interactions increases expression |
ISO |
Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in increased expression of CD36 mRNA] |
CTD |
PMID:35780845 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cdh5 |
cadherin 5 |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of CDH5 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr19:815,415...854,478
Ensembl chr19:815,411...854,368
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO |
tris(chloroethyl)phosphate results in increased expression of CDKN1A protein |
CTD |
PMID:28886428 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Col10a1 |
collagen type X alpha 1 chain |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of COL10A1 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr20:38,183,103...38,189,488
Ensembl chr20:38,182,494...38,189,494
|
|
G |
Col13a1 |
collagen type XIII alpha 1 chain |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of COL13A1 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr20:29,783,965...29,924,116
Ensembl chr20:29,783,965...29,924,032
|
|
G |
Col24a1 |
collagen type XXIV alpha 1 chain |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of COL24A1 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr 2:234,212,256...234,469,445
Ensembl chr 2:234,212,324...234,469,441
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
decreases expression |
ISO |
tris(chloroethyl)phosphate results in decreased expression of CPT1A mRNA |
CTD |
PMID:30966736 |
|
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of CSF1R mRNA |
CTD |
PMID:33367866 |
|
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Cth |
cystathionine gamma-lyase |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of CTH mRNA |
CTD |
PMID:33367866 |
|
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
increases expression multiple interactions decreases expression |
ISO |
tris(chloroethyl)phosphate results in increased expression of CYP11A1 mRNA [tris(chloroethyl)phosphate co-treated with CGB3 protein] results in decreased expression of CYP11A1 mRNA tris(chloroethyl)phosphate results in decreased expression of CYP11A1 mRNA |
CTD |
PMID:22446829 PMID:26049154 PMID:26183808 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp11b3 |
cytochrome P450, family 11, subfamily b, polypeptide 3 |
increases expression |
ISO |
tris(chloroethyl)phosphate results in increased expression of CYP11B2 mRNA |
CTD |
PMID:22446829 |
|
NCBI chr 7:106,808,559...106,814,048
Ensembl chr 7:106,808,559...106,814,048
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
multiple interactions decreases expression |
ISO |
tris(chloroethyl)phosphate inhibits the reaction [CGB3 protein results in increased expression of CYP17A1 mRNA] tris(chloroethyl)phosphate results in decreased expression of CYP17A1 mRNA |
CTD |
PMID:26049154 PMID:26183808 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
increases expression |
ISO |
tris(chloroethyl)phosphate results in increased expression of CYP19A1 mRNA |
CTD |
PMID:22446829 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
decreases expression increases expression |
EXP |
tris(chloroethyl)phosphate results in decreased expression of CYP1A1 protein tris(chloroethyl)phosphate results in increased expression of CYP1A1 mRNA |
CTD |
PMID:30974155 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
multiple interactions decreases expression |
ISO |
Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in decreased expression of CYP27A1 mRNA]; Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in decreased expression of CYP27A1 protein] tris(chloroethyl)phosphate results in decreased expression of CYP27A1 mRNA; tris(chloroethyl)phosphate results in decreased expression of CYP27A1 protein |
CTD |
PMID:35780845 |
|
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
multiple interactions decreases expression |
ISO |
Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in decreased expression of CYP7A1 mRNA] |
CTD |
PMID:35780845 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Cyp8b1 |
cytochrome P450 family 8 subfamily B member 1 |
multiple interactions decreases expression |
ISO |
Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in decreased expression of CYP8B1 mRNA] |
CTD |
PMID:35780845 |
|
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of DDIT3 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ebi3 |
Epstein-Barr virus induced 3 |
increases expression |
ISO |
tris(chloroethyl)phosphate results in increased expression of EBI3 mRNA |
CTD |
PMID:29143341 |
|
NCBI chr 9:774,252...787,544
Ensembl chr 9:783,617...787,544
|
|
G |
Esr1 |
estrogen receptor 1 |
decreases activity |
ISO |
tris(chloroethyl)phosphate results in decreased activity of ESR1 protein |
CTD |
PMID:24844797 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Fasn |
fatty acid synthase |
multiple interactions increases expression |
ISO |
Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in increased expression of FASN protein] tris(chloroethyl)phosphate results in increased expression of FASN mRNA; tris(chloroethyl)phosphate results in increased expression of FASN protein |
CTD |
PMID:35780845 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fgf21 |
fibroblast growth factor 21 |
multiple interactions decreases expression |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of FGF21 mRNA tris(chloroethyl)phosphate results in decreased expression of FGF21 mRNA |
CTD |
PMID:33367866 PMID:35780845 |
|
NCBI chr 1:96,083,360...96,084,911
Ensembl chr 1:96,083,441...96,090,454
|
|
G |
Flcn |
folliculin |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of FLCN mRNA |
CTD |
PMID:33367866 |
|
NCBI chr10:44,588,621...44,607,808
Ensembl chr10:44,588,624...44,607,769
|
|
G |
Foxo3 |
forkhead box O3 |
decreases expression |
ISO |
tris(chloroethyl)phosphate results in decreased expression of FOXO3 protein |
CTD |
PMID:30090360 |
|
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
|
|
G |
Gap43 |
growth associated protein 43 |
decreases expression |
EXP |
tris(chloroethyl)phosphate results in decreased expression of GAP43 mRNA; tris(chloroethyl)phosphate results in decreased expression of GAP43 protein |
CTD |
PMID:24717766 |
|
NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045
|
|
G |
Gdf15 |
growth differentiation factor 15 |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of GDF15 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions increases activity |
ISO |
Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in increased activity of GPT protein] |
CTD |
PMID:35780845 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
increases expression |
ISO |
tris(chloroethyl)phosphate results in increased expression of GPX1 mRNA |
CTD |
PMID:26049154 PMID:26183808 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
increases expression |
ISO |
tris(chloroethyl)phosphate results in increased expression of GPX2 mRNA |
CTD |
PMID:26049154 PMID:26183808 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
increases expression |
EXP |
tris(chloroethyl)phosphate results in increased expression of GSTA2 mRNA |
CTD |
PMID:30974155 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
increases expression decreases expression |
ISO |
tris(chloroethyl)phosphate results in increased expression of GSTA1 mRNA tris(chloroethyl)phosphate results in decreased expression of GSTA1 mRNA |
CTD |
PMID:26049154 PMID:26183808 |
|
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
|
|
G |
Hpx |
hemopexin |
decreases expression |
ISO |
tris(chloroethyl)phosphate results in decreased expression of HPX mRNA |
CTD |
PMID:29143341 |
|
NCBI chr 1:159,932,819...159,940,327
Ensembl chr 1:159,932,755...159,940,328
|
|
G |
Hsd17b13 |
hydroxysteroid (17-beta) dehydrogenase 13 |
decreases expression multiple interactions |
ISO |
tris(chloroethyl)phosphate results in decreased expression of HSD17B13 mRNA tris(chloroethyl)phosphate inhibits the reaction [CGB3 protein results in increased expression of HSD17B13 mRNA] |
CTD |
PMID:26049154 |
|
NCBI chr14:5,751,697...5,766,809
Ensembl chr14:5,752,132...5,768,166
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
decreases expression multiple interactions |
ISO |
tris(chloroethyl)phosphate results in decreased expression of HSD3B1 mRNA [tris(chloroethyl)phosphate co-treated with CGB3 protein] results in decreased expression of HSD3B1 mRNA |
CTD |
PMID:26049154 PMID:26183808 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Hsd3b2 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
increases expression |
ISO |
tris(chloroethyl)phosphate results in increased expression of HSD3B2 mRNA |
CTD |
PMID:22446829 |
|
NCBI chr 2:186,095,897...186,105,354
Ensembl chr 2:186,095,897...186,101,852
|
|
G |
Il6 |
interleukin 6 |
decreases secretion |
ISO |
tris(chloroethyl)phosphate results in decreased secretion of IL6 protein |
CTD |
PMID:28886428 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il6r |
interleukin 6 receptor |
decreases expression |
ISO |
tris(chloroethyl)phosphate results in decreased expression of IL6R protein |
CTD |
PMID:28886428 |
|
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
|
|
G |
Ldlr |
low density lipoprotein receptor |
increases expression decreases expression |
ISO |
tris(chloroethyl)phosphate results in increased expression of LDLR mRNA tris(chloroethyl)phosphate results in decreased expression of LDLR mRNA |
CTD |
PMID:26049154 PMID:26183808 |
|
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Lpl |
lipoprotein lipase |
increases expression multiple interactions |
ISO |
tris(chloroethyl)phosphate results in increased expression of LPL mRNA Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in increased expression of LPL mRNA] |
CTD |
PMID:35780845 |
|
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions |
ISO |
tris(chloroethyl)phosphate results in decreased expression of and results in decreased phosphorylation of MTOR protein |
CTD |
PMID:26378621 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Nefh |
neurofilament heavy chain |
decreases expression increases expression |
EXP |
tris(chloroethyl)phosphate results in decreased expression of NEFH mRNA tris(chloroethyl)phosphate results in increased expression of NEFH protein |
CTD |
PMID:24717766 |
|
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
multiple interactions decreases expression |
ISO |
Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in decreased expression of NR0B2 protein] |
CTD |
PMID:35780845 |
|
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
decreases expression multiple interactions |
ISO |
tris(chloroethyl)phosphate results in decreased expression of NR1H4 mRNA; tris(chloroethyl)phosphate results in decreased expression of NR1H4 protein Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in decreased expression of NR1H4 mRNA]; Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in decreased expression of NR1H4 protein] |
CTD |
PMID:35780845 |
|
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
P2rx7 |
purinergic receptor P2X 7 |
increases expression |
ISO |
tris(chloroethyl)phosphate results in increased expression of P2RX7 mRNA |
CTD |
PMID:29143341 |
|
NCBI chr12:33,889,709...33,934,168
Ensembl chr12:33,879,745...33,934,619
|
|
G |
Pck2 |
phosphoenolpyruvate carboxykinase 2 (mitochondrial) |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of PCK2 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr15:29,027,891...29,036,729
Ensembl chr15:29,027,894...29,037,283
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
decreases expression multiple interactions |
ISO |
tris(chloroethyl)phosphate results in decreased expression of PPARA protein Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in decreased expression of PPARA mRNA]; Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in decreased expression of PPARA protein] tris(chloroethyl)phosphate results in decreased expression of PPARA mRNA; tris(chloroethyl)phosphate results in decreased expression of PPARA protein |
CTD |
PMID:30966736 PMID:35780845 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
decreases expression multiple interactions increases expression |
ISO |
tris(chloroethyl)phosphate results in decreased expression of PPARG protein Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in increased expression of PPARG mRNA]; Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in increased expression of PPARG protein] tris(chloroethyl)phosphate results in increased expression of PPARG mRNA; tris(chloroethyl)phosphate results in increased expression of PPARG protein |
CTD |
PMID:30966736 PMID:35780845 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ptprb |
protein tyrosine phosphatase, receptor type, B |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of PTPRB mRNA |
CTD |
PMID:33367866 |
|
NCBI chr 7:51,953,375...52,034,751
Ensembl chr 7:51,930,015...52,034,748
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
increases expression |
ISO |
tris(chloroethyl)phosphate results in increased expression of RB1 protein; tris(chloroethyl)phosphate results in increased expression of RB1 protein modified form |
CTD |
PMID:28886428 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
decreases expression |
ISO |
tris(chloroethyl)phosphate results in decreased expression of RELA protein; tris(chloroethyl)phosphate results in decreased expression of RELA protein modified form |
CTD |
PMID:28886428 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Runx2 |
RUNX family transcription factor 2 |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of RUNX2 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
|
|
G |
Runx3 |
RUNX family transcription factor 3 |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of RUNX3 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr 5:147,360,587...147,419,161
Ensembl chr 5:147,360,994...147,419,156
|
|
G |
Sirt1 |
sirtuin 1 |
increases expression |
ISO |
tris(chloroethyl)phosphate results in increased expression of SIRT1 mRNA; tris(chloroethyl)phosphate results in increased expression of SIRT1 protein |
CTD |
PMID:26378621 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Sirt3 |
sirtuin 3 |
decreases expression |
ISO |
tris(chloroethyl)phosphate results in decreased expression of SIRT3 mRNA; tris(chloroethyl)phosphate results in decreased expression of SIRT3 protein |
CTD |
PMID:30090360 |
|
NCBI chr 1:195,942,066...195,964,472
Ensembl chr 1:195,942,073...195,964,808
|
|
G |
Smpd3 |
sphingomyelin phosphodiesterase 3 |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of SMPD3 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr19:34,162,337...34,245,786
Ensembl chr19:34,162,341...34,245,749
|
|
G |
Sod1 |
superoxide dismutase 1 |
increases expression |
ISO |
tris(chloroethyl)phosphate results in increased expression of SOD1 mRNA |
CTD |
PMID:26049154 PMID:26183808 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
increases expression decreases expression |
ISO |
tris(chloroethyl)phosphate results in increased expression of SOD2 mRNA tris(chloroethyl)phosphate results in decreased expression of SOD2 protein |
CTD |
PMID:26049154 PMID:26183808 PMID:30090360 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sp7 |
Sp7 transcription factor |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of SP7 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr 7:133,484,609...133,494,788
Ensembl chr 7:133,484,609...133,494,847
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
increases expression multiple interactions |
ISO |
tris(chloroethyl)phosphate results in increased expression of SREBF1 mRNA; tris(chloroethyl)phosphate results in increased expression of SREBF1 protein Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in increased expression of SREBF1 mRNA]; Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in increased expression of SREBF1 protein] |
CTD |
PMID:35780845 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Star |
steroidogenic acute regulatory protein |
decreases expression |
ISO |
tris(chloroethyl)phosphate results in decreased expression of STAR mRNA |
CTD |
PMID:26183808 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Sult1e1 |
sulfotransferase family 1E member 1 |
decreases expression |
ISO |
tris(chloroethyl)phosphate results in decreased expression of SULT1E1 mRNA |
CTD |
PMID:22446829 |
|
NCBI chr14:20,422,324...20,439,562
Ensembl chr14:20,422,324...20,439,275
|
|
G |
Sult2a1 |
sulfotransferase family 2A member 1 |
decreases expression |
ISO |
tris(chloroethyl)phosphate results in decreased expression of SULT2A1 mRNA |
CTD |
PMID:22446829 |
|
NCBI chr 1:75,451,178...75,508,113
Ensembl chr 1:74,911,100...75,508,134
|
|
G |
Tp53 |
tumor protein p53 |
affects binding decreases expression |
ISO |
tris(chloroethyl)phosphate binds to TP53 gene tris(chloroethyl)phosphate results in decreased expression of TP53 protein |
CTD |
PMID:25510514 PMID:28886428 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Trib3 |
tribbles pseudokinase 3 |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of TRIB3 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
|
|
G |
Tspo |
translocator protein |
decreases expression |
ISO |
tris(chloroethyl)phosphate results in decreased expression of TSPO mRNA |
CTD |
PMID:26049154 |
|
NCBI chr 7:114,720,188...114,730,450
Ensembl chr 7:114,720,188...114,730,450
|
|